参考资料（可上下滑动查看）
[1] Michael Böhm, et al., (2020). Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet, DOI: 10.1016/S0140-6736(20)30554-7
[2] More 'Convincing' Data on BP Drop After Renal Denervation. Retrieved Mar 30, 2020, from https://www.medpagetoday.com/meetingcoverage/acc/85672
[3] Michael Böhm, et al., (2020). Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design. Clinical research in cardiology, DOI: 10.1007/s00392-020-01595-z
[4] Robert M. Carey, et al., (2020).Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension, DOI: 10.1161/HYP.0000000000000084
[5] SPYRAL-HTN OFF MED: Renal Denervation Potential Option For Patients with Untreated Hypertension. Retrieved Mar 30, 2020, from https://www.acc.org/latest-in-cardiology/articles/2020/03/24/16/41/sun-1045-spyral-htn-off-med-pivotal-catheter-based-renal-denervation-acc-2020
[6] SYMPLICITYSPYRAL RENAL DENERVATION SYSTEM. Retrieved Mar 30, 2020, from https://global.medtronic.com/xg-en/healthcare-professionals/products/cardiovascular/renal-denervation/symplicity.html